drugset / Trial / NCT02750748
Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
To determine the pharmacokinetics of 2 intranasal doses and 1 oral dose of naltrexone compared to an intramuscular dose of naltrexone.
Timeline
- Start
- 2016-07
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naltrexone | Small molecule | 2 mg | Intranasal |
| Subject | Naltrexone | Small molecule | 4 mg | Intranasal |
| Subject | Naltrexone | Small molecule | 50 mg | Intranasal |